地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:15172431432
邮箱:sales@amyjet.com

Zedira是一家临床阶段的生物技术公司,专门从事转谷氨酰胺酶的研究,开发一系列小分子药物候选物。Zedira公司正致力于药物发现的前沿领域,该领域涉及阻止调节失调的转谷氨酰胺酶的小分子。此外,Zedira是一个全球品牌,专门用于转谷氨酰胺酶领域的研发和诊断试剂,其独特和高质量的产品有助于推动转谷氨酰胺酶的研究和应用。
Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In doing so, the company is working at the cutting edge of drug discovery involving small molecules that block dysregulated transglutaminases. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry.
Zedira公司主要产品:
Transglutaminases
Microbial Transglutaminase
Assays and Substrates
Inhibitors
Antibodies and Microarrays
Proteases
Protein Labeling
Blood Coagulation
Cereal Proteins
Celiac Disease Products
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
Zedira产品详情请咨询我司客服人员:
| 产品编号 | 产品名称 | 产品规格 |
| A003 | Polyclonal antibody to human tissue transglutaminase (TG2) | 100 ug |
| A004 | Monoclonal antibody to tissue transglutaminase (TG2) | 100 ug |
| A008 | Polyclonal antibody to human transglutaminase 5 (TG5) | 500 ug |
| A011 | Monoclonal antibody to gliadin (clone XGY1) | 1 mg |
| A013 | Monoclonal antibody to gliadin (clone XGY7) | 1 mg |
| A014 | Polyclonal antibody to human tissue transglutaminase (TG2) | 500 ug |
| A015 | Polyclonal antibody to human epidermal transglutaminase (TG3) | 500 ug |
| A016 | Polyclonal antibody to human blood coagulation factor XIII (A-subunit) | 500 ug |
| A017 | Polyclonal antibody to human neuronal transglutaminase (TG6) | 500 ug |
| A018 | Polyclonal antibody to human keratinocyte transglutaminase (TGI) | 500 ug |
| A020 | Polyclonal antibody to microbial protransglutaminase (pro-MTG, pro-BTG) | 500 ug |
| A021 | Polyclonal antibody to human plasminogen (rhPLG) | 500 ug |
| A022 | Polyclonal antibody to human prostate transglutaminase (TG4) | 500 ug |
| A023 | Monoclonal antibody to N'-ly-L-glutamylpL-lysine-isopeptide bond | 100 ug |
| A024 | Monoclonal Antibody to microbial (bacterial) Transglutaminase | 100 ug |
| A028 | FITC-labeled polyclonal antibody to human TG2 | 200 ug |
| A029 | FITC-labeled polyclonal antibody to human TGI | 200 ug |
| A030 | FITC-labeled polyclonal antibody to human TG3 | 200 ug |
| A031 | FITC-labeled polyclonal antibody to human TG6 | 200 ug |
| A032 | FITC-labeled polyclonal antibody to human factor XIII (A-subunit) | 200 ug |
| A033 | Monoclonal antibody to human TG2 (Catalytic Domain, clone XTG17) | 200 ug |
| A034 | Monoclonal antibody to human TG2 (Beta Sheet Domain, clone XTG 1 1) | 200 ug |
| A035 | Monoclonal antibodies to gliadin (Set No 1) | 1 Set |
| A036 | Monoclonal antibody to human TG2 (Beta Barrel 1 Domain, clone XTG21) | 200 ug |
| A037 | Monoclonal antibody to human TG2 (Beta Barrel 2 Domain, clone XTG1 8) | 200 ug |
| A040 | Polyclonal antibody to human transglutaminase 7 (TG7) | 200 ug |
| A042 | Monoclonal antibody to human TGI (clone XTG3 1) | 200 ug |
| A044 | FITC-labeled polyclonal antibody to human TG5 | 200 ug |
| A046 | D-Dimer monoclonal mouse antibody, clone 3B6 | 100 ug |
| A047 | D-Dimer monoclonal mouse antibody, clone 1 D2 | 100 ug |
| A051 | Biotinylated polyclonal antibody to microbial transglutaminase (MTG) | 50 ug |
| A052 | Biotinylated polyclonal antibody to human factor XIII (A-subunit) | 50 ug |
| A053 | Biotinylated polyclonal antibody to human TG2 | 50 ug |
| A054 | Monoclonal antibody to gliadin (clone XGY6) | 1 mg |
| A057 | Monoclonal antibody to deamidated gliadin | 100 ug |
| A058 | Monoclonal antibody to gliadin (clone XGY5) | 1 mg |
| A059 | Monoclonal antibody to gliadin (clone XGY9) | 1 mg |
| A060 | Monoclonal antibody to gliadin (clone XGY10) | 1 mg |
| A061 | Monoclonal antibody to gliadin (clone XGY 1 6) | 1 mg |
| A062 | Monoclonal antibody to deamidated and non-deamidated gliadin | 100 ug |
| A063 | Monoclonal antibody to gliadin (clone XGY2) | 1 mg |
| A064 | Monoclonal antibody to gliadin (clone XGY4) | 1 mg |
| A065 | Monoclonal antibody to gliadin (clone XGY8) | 1 mg |
| A066 | Monoclonal antibody to gliadin (clone XGY 1 2) | 1 mg |
| A067 | Monoclonal antibody to gliadin (clone XGY 1 5) | 1 mg |
| A068 | Monoclonal antibody to gliadin (clone XGY 1 7) | 1 mg |
| A069 | Monoclonal antibody to gliadin (clone XGY23) | 1 mg |
| A070 | Monoclonal antibody to gliadin (clone XGY24) | 1 mg |
| A071 | Monoclonal antibody to hordein (clone XH4) | 1 mg |
| A072 | polyclonal antibody to mouse tissue Transglutaminse | 200 ug |
| A074 | Polyclonal antibody to human blood coagulation factor XIII (B-subunit) | 200 ug |
| A075 | FITC-labeled polyclonal antibody to mouse TG2 | 200 ug |
| A076 | DD-XLink-mab | 100 ug |
| A077 | FITC-labeled polyclonal antibody to human factor XIII (B-subunit) | 200 ug |
| A078 | Polyclonal antibody to human epidermal transglutaminase (TG3) Protein A | 250 ug |
| A079 | Biotin-DD-XLink-mab | 50 ug |
| A082 | Monoclonal antibody to human TG3 (clone XTG45) | 200 ug |
| A101 | FXIII-Assay Substance, Abz-NE(CAD-DNP)EQVSPLTLLK-OH | 10 mg |
| A102 | TG2-Assay Substance. Abz-APE(CAD-DNP)QEA-OH | 10 mg |
| A105 | NQEQVSPLTLLK, alpha2-Antiplasmin peptide (1-12) | 25 mg |
| A106 | (ATTO-48 8TM)cadaveri ne | 1 mg |
| A108 | Ac-(D)-Asp-MA-N le-Nle-Leu-Pro-Trp-Pro-OH | 5 mg |
| A109 | β-Amyloid peptide 1-42 (Aβ 1-42) | 1 mg |
| A112 | (ATTO-532)cadaverine | 1 mg |
| A113 | (ATTO-550)cadaverine | 1 mg |
| A114 | (AnO-647N)cadaverine | 1 mg |
| A115 | (ATTO-700)cadaverme | 1 mg |
| A125 | Factor XIII activation peptide | 10 mg |
| A132 | Ac-WALQRPHYSYPD | 10 mg |
| A139 | Monoclonal antibody to human TG6 (Catalytic Domain, clone XTG52) | 200 ug |
| A140 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG39) | 200 ug |
| A141 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG68) | 200 ug |
| A142 | Monoclonal antibody to human TG6 (Beta Barrel 2 Domain, clone XTG57) | 200 ug |
| A143 | Monoclonal antibody to microbial Transglutaminase (clone XM67) | 200 ug |
| A144 | Monoclonal antibody to microbial Transglutaminase (clone XM68) | 200 ug |
| A145 | Polyclonal Antibody to microbial Transglutaminase | 200 ug |
| A152 | 3-Azido-l -propanamine | 100 mg |
| A153 | 4-Azidobutan-l-amine | 100 mg |
| A154 | Monoclonal antibody to human factor XIII (Activation Peptide, clone XTG09) | 200 ug |
| A155 | Monoclonal antibody to human factor XIII (Catalytic Domain, clone XTG02) | 200 ug |
| B001 | Biotinyl-Thr-Val-GIn-GIn-Glu-Leu-OH | 5 mg 25 mg |
| B002 | N-(Biotinyl)cadaverine | 25 mg 100 mg |
| B003 | Boc-DON-Gln-lle-Val-OMez "Boc-DON” | 10 mg |
| B006 | Thr-Val-Gln-Gln-Glu-Leu-OH | 25 mg |
| B007 | Keratinocyte transglutaminase (TGI )-substrate-peptide K5 | 10 mg |
| B008 | Tissue transglutaminase (TG2)-substrate-peptide T26 | 10 mg |
| B009 | Epidermal transglutaminase (TG3)-substrate-peptide E51 | 10 mg |
| B010 | Blood coagulation FXIII-substrate-peptide Fl 1 KA | 10 mg |
| B013 | Neuronal transglutaminase (TG6)-substrate peptide Y25 | 10 mg |
| B014 | Transglutaminase 7 (TG7)-substrate peptide Z3S | 10 mg |
| B015 | Biotin-Ahx-MA-QPL-OMe | 10 mg |
| B017 | Microbial Transglutaminase (MTG)-substrate peptide M48 | 10 mg |
| B019 | Biotin-Ahx-QVPL-OMe | 10 mg |
| C001 | Z-GIn-Gly-OH | 1g |
| C002 | Z-GIn-Gly-CAD-DNS | 25 mg 100 mg |
| C074 | Z-Gln-Gly-CAD-(AnO-488) | 1 mg |
| C075 | Z-Gln-Gly-CAD-(ATTO-532) | 1 mg |
| C076 | Z-Gln-Gly-CAD-(AnO-550) | 1 mg |
| C077 | Z-Gln-Gly-CAD-(ATTO-647N) | 1 mg |
| C078 | Z-Gln-Gly-CAD-(AnO-700) | 1 mg |
| C079 | Z-GIn-Gly-PEG(3)-N3 | 25 mg |
| C080 | Z-Gln-Gly-PEG(11)-N3 | 25 mg |
| C090 | Z-GIn-Gly-CAD-TAMRA | 25 mg |
| C091 | Z-GIn-Gly-CAD-Biotin | 25 mg |
| C092 | Z-Gln-Gly-(PEG1,088), monodisperse | 25 mg |
| C093 | Z-Gln-Gly-(PEG5,000), polydisperse | 25 mg |
| C094 | Tosyl-ε-aminopentyl-CMK | 1 mg |
| C095 | Dansyl-ε-aminopentyl-CMK | 1 mg |
| C102 | MTG Blocker | 10 mg 25 mg |
| D001 | Dansyl-ε-aminohexanoyl-GIn-GIn-lle-Val-OH | 25 mg 100 mg |
| D002 | N-(2,4-Dinitrophenyl)cadaverine | 100 mg |
| D003 | 1,3-Dimethyl-2[(2-oxo-propyl)thio]imidazolium chloride | 100 mg |
| D004 | 1,3-Dimelhyl-4,5-diphenyl-2-[(2-oxopropyl)thio]imidazolium | 10 mg |
| D005 | Metalloprotease-Assay-Substance, DABCYL-Ser-Phe-EDANS | 2 mg |
| D006 | N-(Dansyl)cadaverine | 100 mg |
| D007 | Cadaverine | 100 mg |
| D008 | "DALP", DNP-aminohexanoic acid-Lys-aminopropanol | 5 mg |
| D009 | DALP-methyl carbamate | 5 mg |
| D0I 6 | LDN 27219 | 10 mg |
| E018 | ZediXclusive Tissue Transglutaminase EIA | 1 Kit |
| E021 | ZediXclusive Microbial Transglutaminase (MTG) ELISA | 1 Kit |
| E103 | ZediXclusive TG6-ab ELISA (IgA) | 1 Kit (96 wells) |
| E104 | ZediXclusive TG6-ab ELISA (IgG) | 1 Kit (96 wells) |
| F001 | FXIII-Assay Kit | 1 Kit |
| F002 | Tissue Transglutaminase Assay Kit | 1 Kit |
| F004 | Fibrinogen, purified from human plasma | 50 mg |
| F006 | FITC-labeled Fibrinogen | 5 mg |
| F007 | Fibrin Glue (porcine) | 1 Kit |
| F008 | Fibrin Glue (bovine) | 1 Kit |
| F011 | Cross-linked fibrin degradation products, xFDPs | 200 ug |
| F012 | Fibrin degradation products, FDPs | 200 ug |
| G001 | Alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G002 | Deamidated alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G003 | Ac-PLQPEQPFPK(ε-Biotin), Deamidated gliodin peptide | 10 mg |
| G004 | Ac-PEQLPQFEEK(ε-Biotin), Deamidated gliadin peptide | 10 mg |
| G005 | DGPx4 (Fusion protein of 4 deamidated gliadin peptides) | 500 ug |
| G006 | DGPx2 (Fusion protein of 2 deamidated gliadin peptides) | 500 ug |
| G007 | DGPxl (deamidated gliadin peptide) | 500 ug |
| G008 | Omega-5 gliadin | 500 ug |
| G009 | Alpha2-gliadin, 33mer (aa 56-88) | 5 mg |
| G011 | Deamidated alpha2-gliadin, 33mer, (Acetyl-aa56-88-amide, Q65E) | 5 mg |
| G013 | QPFPQPQLPYPQPQ-amide | 10 mg |
| G014 | QPFPQPELPYPQPQ-amide | 10 mg |
| G017 | Biotinylated DGPx1 | 100 ug |
| G018 | Barley albumin and globulin | 5 mg |
| G019 | Barley prolamin (Hordein) | 5 mg |
| G020 | Barley glutelin (Hordenin) | 5 mg |
| G021 | Rye albumin and globulin | 5 mg |
| G022 | Rye prolamin (Secalin) | 5 mg |
| G023 | Rye glutelin (Secalinin) | 5 mg |
| G024 | Corn albumin and globulin | 5 mg |
| G025 | Corn prolamin (Zein) | 5 mg |
| G026 | Corn glutelin (Zeanin) | 5 mg |
| G027 | Rice albumin and globulin | 5 mg |
| G028 | Rice prolamin (Oryzin) | 5 mg |
| G029 | Rice glutelin (Oryzenin) | 5 mg |
| G030 | Spell albumin and globulin | 5 mg |
| G031 | Spelt prolamin | 5 mg |
| G032 | Spelt glutelin | 5 mg |
| G033 | Oat albumin and globulin | 5 mg |
| G034 | Oat prolamin (Avenin) | 5 mg |
| G035 | Oat glutelin (Avenalin) | 5 mg |
| G036 | Wheat albumin and globulin (Leukosin and Edestin) | 5 mg |
| G037 | Wheat prolamin (Gliadin) | 5 mg |
| G038 | Wheat glutelin (Glutenin) | 5 mg |
| G039 | Durum wheat albumin and globulin | 5 mg |
| G040 | Durum wheat prolamin | 5 mg |
| G041 | Durum wheat glutelin | 5 mg |
| G042 | Soy protein, saline soluble fraction | 5 mg |
| G043 | Soy protein, ethanol soluble fraction | 5 mg |
| G044 | Soy protein, propanol/urea/DTE soluble fraction | 5 mg |
| G045 | Millet (Sorghum) albumin and globulin | 5 mg |
| G046 | Millet (Sorghum) prolamin (Kafirin) | 5 mg |
| G047 | Millet (Sorghum) glutelin | 5 mg |
| G048 | L-Glutamic acid γ-monohydroxamate | 100 mg |
| G051 | 26mer gliadin peptide | 250 ug |
| G052 | 33mer gliadin peptide | 250 ug |
| G054 | 33mer DGP | 250 ug |
| G055 | Carrier protein control | 250 ug |
| G056 | DGP and Gliadin peptides (Set No 1) | 1 Set |
| G057 | Alpha2-gliadin, 33mer (aa56-88), TAMRA labeled | 5 mg |
| G058 | Alpha2-gliadin, 33mer (aa56-88), TAMRA and Biotin labeled | 5 mg |
| G101 | Gly-Pro-Arg-Pro-amide | 25 mg |
| I001 | Involucrme, recombinant human | 500 ug |
| K004 | "KxD", Boc-Lys-en-DNS | 10 mg |
| L001 | Substrate Finder Kit | 1 Kit |
| L101 | Biotin TGase Protein Q-Labeling Kit | 1 Kit |
| L102 | PEG1,088 TGase Protein Q-Labeling Kit | 1 Kit |
| L103 | PEG5,000 TGase Protein Q-Labeling Kit | 1 kit |
| L104 | ATTO-488™ TGase Protein Q-Labeling Kit | 1 Kit |
| L105 | ATTO-532™ TGase Protein Q-Labeling Kit | 1 Kit |
| L106 | ATTO-550™ TGase Protein Q-Labeling Kit | 1 Kit |
| L107 | ATTO-647N™ TGase Protein Q-Labeling Kit | 1 Kit |
| L108 | ATTO-700™ TGase Protein Q-Labeling Kit | 1 Kit |
| L201 | Biotin TGase Protein K-Labeling Kit | 1 Kit |
| L202 | PEG1,088 TGase Protein K-Labeling Kit | 1 Kit |
| L203 | PEG5,000 TGase Protein K-Labeling Kit | 1 Kit |
| L204 | ATTO-488™ TGase Protein K-Labeling Kit | 1 Kit |
| L205 | ATTO-532™ TGase Protein K-Labeling Kit | 1 Kit |
| L206 | ATTO-550™ TGase Protein K-Labeling Kit | 1 Kit |
| L207 | ATTO-647N™ TGase Protein K-Labeling Kit | 1 Kit |
| L208 | ATTO-700™ TGase Protein K-Labeling Kit | 1 Kit |
| M001 | MTG-ANiTA-Kit | 1 Kit |
| M003 | Tissue Transglutaminase Pico-Assay Kit | 1 Kit |
| P003 | Prolylendopeptidase from Myxococcus xanthus, recombinant | 150U |
| P004 | PT-Gluten | 1 mg 10 mg |
| P009 | human Pro-Glu-Plasminogen, recombinant | 100 ug |
| P010 | (PEG1,088)amine, monodisperse | 10 mg |
| P011 | (PEG5,000)amine, polydisperse | 10 mg |
| P012 | human Plasmin, recombinant | 100 ug |
| P0U | Urokinase | 1 mg |
| P015 | Streptokinase (bacterial plasminogen activator) | 1 mg |
| P016 | Tissue Plasminogen Activator | 100 ug |
| P111 | PEPperCHIP Pan-Transglutaminase Microarray | 1 Chip |
| P112 | PEPperCHIP Custom Transglutaminase Microarray | 1 Chip |
| P113 | PEPperCHIP Transglutaminase Microarray Service | 1 Sample |
| P114 | PepSlide Analyzer | 3-Month/1-Year/Perpetual License |
| P115 | PEPperCHIP Incubation Tray 3/1 | 1 Tray |
| P116 | PEPperCHIP Staining Kit | 1 Kit |
| P117 | PEPperCHIP Transglutaminase 2 Microarray | 1 Chip |
| P118 | PEPperCHIP Incubation Tray 3/5 | 1 Tray |
| R001 | N-(Tetrametylrhodaminyl)cadaverine | 10 mg |
| R002 | TAMRA-DON | 5 mg 10 mg |
| T001 | Microbial (bacterial) transglutaminase | 25 U; 1 x 250 U;10x 25 U; lx 500 U; 20x 25 U |
| T002 | Human tissue transglutaminase (TG2) | 250 ug 1mg |
| T004 | N-(p-Tosyl)-Gly-Pro-Lys-pNA | 25 mg |
| T006 | Guinea pig liver transglutaminase | 10U |
| T009 | Human keratinocyte transglutaminase (TG1) | 150 ug |
| T011 | Human transglutaminase 7 | 250 ug |
| T013 | Human epidermal transglutaminase, Dispose activated | 200 ug |
| T016 | Microbial (bacterial) Pro-transglutaminase | 250 ug |
| T018 | Inactive human tissue transglutaminase | 250 ug 1 mg |
| T021 | Human neuronal transglutaminase (TG6) | 250 ug |
| T022 | Human tissue transglutaminase (TG2) | 250 ug 1 mg |
| T024 | Human epidermal transglutaminase (TG3) | 200 ug |
| T027 | Human blood coagulation Factor Xlll-A z recombinant | 200 ug |
| T034 | Human tissue transglutaminase (TG2) | 100 ug |
| T035 | Human keratinocyte transglutaminase (TGI) | 150 ug |
| T036 | Transglutaminase Assay Kit, fluorescent, Casein, Dansylcadaverine | 1 Kit |
| T038 | Rat tissue transglutaminase | 250 ug 1 mg |
| T039 | Guinea pig liver transglutaminase, recombinant | 10U |
| T040 | Mouse tissue transglutaminase | 250 ug 1 mg |
| T042 | Human prostate Transglutaminase (TG4) | 100 ug |
| T050 | Human blood coagulation Factor XIII B subunit | 200 ug |
| T051 | Open tTG™ | 250 ug |
| T055 | Tissue Transglutaminase Microassay Kit, colorimetric | 1 Kit |
| T056 | Human alpha thrombin, highly active | 200 U |
| T057 | Inhibited human epidermal transglutaminase | 250 ug |
| T061 | Mouse blood coagulation Factor Xlll-A2 | 200 ug |
| T062 | Dog blood coagulation Factor Xlll-A2 | 200 ug |
| T063 | Human blood coagulation Factor Xlll-A2 , Val34Leu-mutant | 200 ug |
| T064 | Inhibited human neuronal transglutaminase | 250 ug |
| T065 | Rat blood coagulation Factor Xlll-A2 | 200 ug |
| T066 | Pig blood coagulation Factor Xlll-A2 | 200 ug |
| T067 | Human tissue transglutaminase (TG2), endotoxin free | 250 ug 1 mg |
| T070 | Human Factor Xllla, Thrombin activated | 200 ug |
| T072 | Dog tissue transglutaminase | 250 ug 1 mg |
| T086 | Human Transglutaminase 5 | 100 ug |
| T087 | Tridegin | 200 ug |
| T092 | Human blood coagulation Factor Xlll-A2 | 100 ug |
| T101 | 1,3,4,5-Tetramethyl-2[(2-oxo-propyl)thio] imidazolium chloride | 10 mg |
| T102 | Mouse Open TG2 | 250 ug 1 mg |
| T106 | Biotinylated human tissue transglutaminase (TG2) | 100 ug 250 ug |
| T108 | Cynomolgus tissue transglutaminase | 250 ug |
| T109 | Cynomolgus open TG2 | 100 ug |
| T1 10 | Recombinant TG2 [E.coli] | 500 ug |
| T1 14 | Blood Coagulation Factor Xlll-Microassay Kit, colorimetric | 1 Kit |
| T117 | Biotinylated inactive hTG2 (Cys277Ser) | 250 ug 1 mg |
| T122 | Recombinant TG2 (insect cells) | 500 ug |
| T123 | Biotinylated human tissue transglutaminase (TG2) | 50 ug |
| T124 | Recombinant TG3 (insect cells) | 400 ug |
| T127 | Biotinylated human blood coagulation Factor XIII | 50 ug |
| T134 | Open tTG™ | 100 ug |
| T139 | Rabbit tissue transglutaminase | 250 ug 1mg |
| T140 | Biotinylated human epidermal transglutaminase | 100 ug |
| T141 | Biotinylated human neuronal transglutaminase | 100 ug |
| T142 | Biotinylated mouse blood coagulation Factor Xlll-A2 | 50 ug |
| T146 | Mouse neuronal transglutaminase | 250 ug |
| T148 | Biotinylated human Open tTG™ | 50 ug 1 mg |
| T149 | Oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T150 | Biotinylated mouse open TG2 | 50 ug |
| T151 | Biotinylated oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T152 | Rabbit blood coagulation Factor Xlll-A2 | 200 ug |
| T153 | Microbial (bacterial) transglutaminase, edotoxin free | 25 U;10x 25 U;20x 25 U |
| T156 | Biotinylated mouse tissue transglutaminase | 250 ug; 1 mg |
| T159 | Pig tissue transglutaminase | 250 ug; 1 mg |
| T160 | Biotinylated cynomolgus tissue transglutaminase | 50 ug |
| T161 | Cynomolgus blood coagulation Factor Xlll-A2 | 200 ug |
| T167 | Short human tissue transglutaminase, aa 1-475 | 250 ug |
| T168 | Human tissue transglutaminase, C23OA mutant | 250 ug;1 mg |
| T169 | Human tissue transglutaminase, R580A mutant | 250 ug;1 mg |
| T173 | Human tissue transglutaminase, R116C mutant | 1 mg |
| T178 | Microbial transglutaminase with C-terminal His6-tag | 25 U;10 x 25 U;20 x 25 U |
| T184 | Cat tissue transglutaminase | 200 ug |
| T187 | Factor XIII activation peptide, recombinant | 500 ug |
| T197 | Coagulation factor XIII, recombinant human Factor Xlll-A2 | 100E;250E |
| T222 | Human alpha Thrombin, recombinant | 100 NIH Units |
| Z004 | Z-Gln-GIn-Pro-Leu-OH | 25 mg |
| Z006 | Z-DON-Val-Pro-Leu-OMe,"Z-DON" | 10 mg |
| Z009 | ZediXclusive Microbial Transglutaminase Assay Kit | 1 Kit |
| Z010 | ZediXclusive Tissue Transglutaminase Assay Kit | 1 Kit |
| Z011 | Z-(D)-DON-Val-Pro-Leu-OMe | 10 mg |
| Z013 | Z-MA-QPL-OMe | 10 mg |
| Z015 | Keillor inhibitor AA9 | 10 mg |
| Z016 | Keillor inhibitor NC9 | 10 mg |
| Z017 | Keillor inhibitor VA4 | 10 mg |
<艾美捷科技代理Clearsynth品牌全系列产品
Clearsynth研发中心位于海得拉巴,以“创新与精准之心”为核心理念,打造了一个精心设计的空间,旨在激发突破性的发现并提升可能性的界限。专注于创新有机化学和独特复杂分子的合成,涵盖稳定同位素标记化合物、代谢物、杂质、葡萄糖醛酸、手性化合物、共轭物杂质和放射性标记化合物等。承接复杂分子或“难以合成”的合成化合物/中间体的定制合成服务。提供超过3,59,000个高纯度参考标准品,Clearsynth公司的产品线包括稳定同位素、原料药、杂质、亚硝胺、二级标准、散装化合物等。

▍Clearsynth服务领域
● 小分子:合成各种精细化学品和化合物,用于从毫克到数公斤规模的小分子药物发现。
● 工艺开发:开发新的合成路线,也可以修改和优化客户提供的工艺。
● 合同研发综合:专注于从临床前阶段到III期以及成功的技术转让。
● 生物核磁共振服务:位于海得拉巴的符合GLP标准的高场生物核磁共振/600MHz和300MHz设施,由敬业且经验丰富的核磁共振操作员提供支持。
● CDMO服务:致力于复杂、危险和可持续的产品和工艺。
● 分析服务:符合FDA、BIS、卫生部和其他标准机构制定的所有监管规范。
▍Clearsynth部分产品列表
| 品名 | 货号 | CAS号 |
| α-Keto Isovaleric Acid Sodium Salt 13C D6 | CS-R-00562 | 3715-29-5 (Unlabeled) |
| α-Keto Isovaleric Acid Sodium Salt 13C5 | CS-R-00482 | 1173018-24-0 |
| α-Keto Isovaleric Acid Sodium Salt D6 | CS-R-00485 | 3715-29-5(Unlabeled) |
| α-Keto Isovaleric Acid Sodium Salt Dimethyl-13C2 | CS-R-00488 | 634908-42-2 |
| α-KETOBUTYRIC ACID, SODIUM 13C, D4 | CS-R-00475 | 2013-26-5 (Unlabeled) |
| α-KETOBUTYRIC ACID, SODIUM SALT 13C4, D2 | CS-R-00477 | 360769-17-1 |
| α-KETOBUTYRIC ACID, SODIUM SALT METHYL-13C | CS-R-00478 | 634908-43-3 |
| α-KETOBUTYRIC ACID, SODIUM SALT METHYL-13C, D2 | CS-R-00479 | 1007476-77-8 |
| α-Ketobutyric Acid-d2 Sodium Salt | CS-T-30294 | 1007476-82-5 |
| α-Ketoglutaric acid 13C2, D2 | CS-CX-00331 | 123953-28-6 |
| α-KETOGLUTARIC ACID 13C5 | CS-R-00549 | 161096-83-9 |
| α-KETOGLUTARIC ACID, DISODIUM SALT 13C4 | CS-R-00480 | 1429051-79-5 |
| α-KETOISOCAPROIC ACID 13C | CS-R-00551 | 92751-19-4 |
| α-KETOISOCAPROIC ACID, SODIUM SALT 13C2 | CS-R-00552 | 4502-00-5(Unlabeled) |
| α-KETOISOCAPROIC ACID, SODIUM SALT ISOPROPYL-D7 | CS-R-00555 | 1795020-84-6 |
| α-Tocopherol-[13C3] | CS-I-00340 | 59-02-9 (Unlabeled) |
| β-ALANINE 13C | CS-R-00042 | 65138-34-3 |
| β-ALANINE 13C, 15N | CS-R-00449 | 1822942-84-6 |
| β-ALANINE 13C3 | CS-R-00040 | 107-95-9 (Unlabeled) |
| β-ALANINE 15N | CS-R-00041 | 204451-53-6 |
| β-CAROTENE 13C4 | CS-R-00567 | 7235-40-7(Unlabeled) |
| -β-Cyclocitral-d5 | CS-T-51410 | 78995-98-9 |
| β-Endosulfan D4 | CS-O-15034 | 203716-99-8 |
| β-Ionone-[13C3] | CS-I-00368 | 14901-07-6 (Unlabeled) |
| βmethasone 17-propionate-d3 | CS-O-10426 | 5534-13-4 (Unlabeled) |
| β-Tocopherol-[13C9] | CS-I-00341 | 59-02-9 (Unlabeled) |
| γ-HCH D6 | CS-EJ-0009 | 60556-82-3 |
| (-)-(2S,3S)-Viridifloric Acid Acetonide-d7 | CS-T-102816 | 95462-09-2(Unlabelled) |
| (-)-(2S,3S)-Viridifloric Acid Ethyl Ester-d7 | CS-T-102815 | 176712-53-1(Unlabelled) |
| (-)-(3S)-3-Hydroxy Quinine-vinyl-d3 | CS-T-101262 | 2734920-65-9 |
| (-)-(S)-Cibenzoline-D4 | CS-O-33254 | 103419-18-7 (Unlabeled) |
| (-)-2-Amino-6-propionamido-d3-tetrahydrobenzothiazole | CS-T-97805 | 1217644-20-6 |
| (-)-2-Methyl Isoborneol-d3 | CS-T-58298 | 135441-89-3 |
| (-)-alfa-Benidipine-d5 Hydrochloride | CS-P-07295 | 129262-07-3 (Unlabeled) |
| (-)-Cannabidiol-d9 | CS-TA-86322 | 1246819-21-5 |
| (-)-Citrinin-13C,d2 | CS-T-72877 | 1329611-85-9 |
<艾美捷科技代理Purepeg品牌全系列产品
PurePEG, LLC是一家致力于为学术和商业用户提供高质量、高纯度单分散聚乙二醇(PEG)及其相关产品的领先供应商,提供具有不同重复单元(间隔基长度)、末端官能团(X 和 Y)以及多种分子结构(线性、支化和多臂型)的产品。PurePEG 凭借多年研发积累的创新 PurePEG 技术,能够生产具有精确分子量的纯净、单分散 PEG。PurePEG 开发了首个用于偶联抗体与毒素(ADC药物)以治疗乳腺癌的酸功能化PEG。PEG因其水溶性、无毒性和非免疫原性等特性,已在生物医学领域确立了重要地位。迄今为止,已有 12 种经 FDA 批准的聚乙二醇化药物用于治疗多种慢性疾病。此外,PurePEG提供从毫克级到公吨级多种PEG产品的高质量定制合成与合同研发服务。

▍Purepeg产品线
PurePEG提供以下相关目录产品:
| Diselenide Linkers | Clickable Linkers | PEG45 | Linker with protecting group |
| Peptide Linkers | BCN Linker | PEG-Lipid | Biotinylation Reagents |
| Polydisperse PEG | BCN linker (non PEG) | PEGylation Reagents | Multi-Arm PEGs |
| PROTAC | Diazirine Linker | Heterobifunctional PEGs | Cleavable Linkers |
| Chelating Agent | Porphyrin | Homobifunctional PEGs | Non-PEG Linkers |
▍Purepeg部分产品列表
| 品名 | 货号 | CAS号 | 分子式 | 分子量 |
| 3,3′-Diselenobispropionic acid | 512371 | 7370-58-3 | C6H10O4Se2 | 304.06 |
| di-tert-butyl 3,3′-diselanediyldipropionate | 512282 | N/A | C14H26O4Se2 | 416.3 |
| 2,2′-diselanediyldiacetic acid | 512361 | 16066-50-5 | C4H6O4Se2 | 276.01 |
| di-tert-butyl 2,2′-diselanediyldiacetate | 512281 | N/A | C12H22O4Se2 | 389.98 |
| Azido-PEG4-Val-Ala-PAB-PNP | 5126604 | N/A | C33H45N7O12 | 731.8 |
| Azido-PEG4-Val-Ala-PAB | 5116604 | N/A | C26H42N6O8 | 566.7 |
| Mal-amide-PEG6-Val-Cit-PAB-OH | 516206 | 3034751-42-0 | C40H63N7O14 | 865.4 |
| Mal-PEG8-amide-Val-Ala-Exatecan | 5116208 | N/A | C58H78FN7O18 | 1179.539 |
| MC-Val-Cit-PAB-PNP | 51057 | 159857-81-5 | C35H43N7O11 | 737.8 |
| MC-Val-Ala-PAB-OH | 51056 | 1870916-87-2 | C25H34N4O6 | 486.56 |
| MC (C5)-Val-Cit | 51055 | 2504147-59-3 | C20H31N5O7 | 453.5 |
| SPDP-Val-Cit-PAB-PNP | 51054 | N/A | C33H39N7O9S2 | 741.8 |
| SPDP-Val-Cit-PAB-OH | 51053 | N/A | C26H36N6O5S2 | 576.7 |
| Alloc-Val-Ala-PAB | 51051 | 1343407-91-9 | C19H27N3O5 | 377.4 |
| DBCO-PEG4-Val-Ala-PAB | 5114804 | 2348405-92-3 | C45H57N5O10 | 827.9 |
| Boc-PEG2-Val-Cit-PAB-OH | 512702 | 2055024-55-8 | C30H50N6O9 | 638.75 |
| endo BCN-PEG3-VC-PFP Ester | 5196303 | 2353409-45-5 | C37H50F5N5O10 | 819.8 |
| endo BCN-PEG3-Val-Cit | 511203 | N/A | C31H51N5O10 | 653.8 |
| Azido-PEG3-Val-Cit-PAB-PNP | 516603 | 2055047-18-0 | C34H47N9O12 | 773.8 |
| Azido-PEG4-Val-Cit-PAB-OH | 516604 | 2055024-64-9 | C29H48N8O9 | 652.8 |
| Boc-PEG4-Val-Cit-PAB-OH | 512704 | 2055024-54-7 | C34H58N6O11 | 726.86 |
| Boc-PEG6-Val-Cit-PAB-OH | 512706 | 2055024-53-6 | C38H66N6O13 | 814.96 |
| 6-Azidohexanoyl-Val-Cit-PAB | 51047 | 1613321-01-9 | C24H38N8O5 | 518.61 |
| DBCO-PEG4-Val-Cit-PAB-PNP | 514804 | 2226472-28-0 | C55H66N8O15 | 1079.2 |

艾美捷科技代理HaemoScan 品牌。
HaemoScan专注于血液相容性测试和生物标志物分析,致力于为血液接触医疗设备和新候选药物提供临床前体外测试服务,帮助研究者更深入地了解产品或获得批准将其产品快速推向市场。除了提供专业的测试服务外,HaemoScan还销售基于内部开发方法的测试试剂盒。
检测产品包括:
(1)血液相容性测试:HaemoScan在医用管和医用流体袋的血液相容性测试方面具有丰富经验。这些测试有助于了解聚合物、添加剂和化合物对血液的影响,以及选择和塑料选择对产品设计的影响。
(2)生物标志物分析:HaemoScan提供生物标志物检测试剂盒,用于评估血液和生物材料之间的相互作用以及先天免疫活性(如补体活性)。
(3)测试试剂盒:HaemoScan的实验室方法已经转换为即用型检测试剂盒,这些试剂盒主要用于评估血液和生物材料之间的相互作用,以及测量血浆中经典和替代途径的补体活性。
<<<< " data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理HaemoScan品牌"> 艾美捷科技代理HaemoScan品牌
艾美捷科技代理Ambrothian品牌全系列产品
Ambrothian是一家专门生产LB培养基的公司。Ambrothian的LB Broth是世界上首创的颗粒状的LB培养基。具有以下特点:
● 欧洲原料,品质可靠: 研究培养基的价值在于其培养性能。Ambrotia 的LB肉汤选用久经验证的欧洲原料(非劣质原料),以实现最佳培养效果。坚固的条状包装采用高密度遮光/防潮/密封材料,能确保单个培养基的品质在一年以上不受湿气影响。
● 三秒搞定,一键式条状包装: 无需担心电子秤称重的繁琐,也告别了将粉末瓶插入烧瓶颈部的不便。采用精确至小数点后的定量条状包装,配制培养液的速度较快。
● 零粉尘,高溶解颗粒技术:Ambrotia凭借全球首创的银星状颗粒,完美解决了现有粉末培养基的粉尘问题。它遇水即沉并能快速溶解,无需费力摇晃。


艾美捷科技代理Ludger品牌。
Ludger成立于1999年,位于英国牛津,是一家专注于糖科学(Glycoscience)和生物制药分析的公司,致力于为生物制药行业提供高质量的糖分析产品和服务。Ludger公司主要业务包括:
(1)糖分析产品:提供多种用于糖蛋白、糖脂和聚糖分析的标准品、试剂盒和仪器。
(2)分析服务:提供全面的糖分析服务,包括糖基化分析、糖结构鉴定和定量分析。
(3)定制化解决方案:根据客户需求,提供定制化的糖分析方案和研究服务。
Ludger公司产品线包括糖标准品、糖分析试剂盒、糖芯片、糖分析软件等;其采用先进的质谱技术、液相色谱技术和糖芯片技术,确保分析结果的高灵敏度和高准确性。Ludger公司产品应用范围包括:生物制药,涵盖单克隆抗体、融合蛋白、疫苗等生物制药产品的开发和质控;生物医学研究,支持糖生物学、糖免疫学、糖组学等研究领域;临床诊断,用于糖生物标志物的开发和临床应用,助力疾病早期诊断和个性化治疗。
<<<<<< " data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Ludger品牌"> 艾美捷科技代理Ludger品牌
<艾美捷科技代理Nanomed3D品牌全系列产品
Nanomed3D是一家专注于纳米生物技术的公司,致力于设计和生产用于研究、医疗器械和未来疗法的专有功能化自组装肽。公司拥有一支多学科团队,在神经再生、组织工程、纳米医学和材料科学等领域拥有二十多年的专业知识,涵盖纳米材料、干细胞收获和移植、GMP生产、分子建模、静电纺丝、药物释放、肽合成、新型生物辅体的体外和体内测试等多个方面。

▍Nanomed3D产品线
● ASSAP水凝胶:
ASSAP水凝胶即抗扩散自组装肽水凝胶,是一种合成基质,由标准合成氨基酸(1% w/v)和99%水的明确混合物组成。核心成分为抗扩散自组装肽(ASSAP)。在生理条件下,肽组分自组装成3D水凝胶,呈现出纳米级纤维结构。作用机制与优势主要包括以下几个方面:
①抑制细胞扩散:其纳米结构亲水水凝胶能够有效抑制细胞粘附和扩散,同时提供纳米结构合成微环境。这种特性使得它可以根据特定细胞类型进行调整,从而培养出“难以培养”的细胞,如肺、乳腺和结肠干细胞。
②模仿生理生态位:作为第一个可供分发的Nanomed3D SAP,ASSAP提供了细胞外基质的典型纳米结构形貌,模仿了组织中发现的干细胞的生理生态位。它最大限度地减少细胞扩散,而不阻止细胞低附着,促进了细胞的增殖并保留了细胞的干性。
| Name | Size | Solvent | Regulatory Status | Storage |
| ASSAP Hydrogel | 5 mL | dH2O | RUO | +2 – +6° C |
| ASSAP Hydrogel | 10 mL | dH2O | RUO | +2 – +6° C |
● PASAP水凝胶:
PASAP 水凝胶是一种合成基质,用于为多种细胞培养实验创建特定的三维(3D)微环境。PASAP 纳米结构亲水性水凝胶具有多种功能化特性,能够促进多种细胞(如神经干细胞、间充质干细胞、内皮细胞和成纤维细胞)的附着、分化和存活。PASAP 具有细胞外基质特有的纳米结构形貌,从而模拟活组织中细胞周围的生理微环境。
| Name | Size | Solvent | Regulatory Status | Storage |
| PASAP Hydrogel | 5 mL | dH2O | RUO | +2 – +6° C |
| PASAP Hydrogel | 10 mL | dH2O | RUO | +2 – +6° C |
● 定制水凝胶:
定制范围涵盖纳米结构支架的化学连接、生物力学调节、仿生模拟以及孔隙率设计。根据需求,还可通过静电纺丝制成固态、具有柔韧性且形状各异的框架。

● Nanomed3D 纳米保湿剂:
这种水凝胶具备卓越的保湿性能,同时还能促进皮肤中胶原蛋白与弹性蛋白的生成,采用纯合成成分,不含有害物质。
<艾美捷科技代理AkrivisBio品牌全系列产品
AkrivisBio是生命科学与生物技术领域的研究产品供应商,公司名"Akrivis"源自古希腊语,意为"精准",彰显企业核心理念;"Bio"则界定我们其专业领域。AkrivisBio公司的核心产品线包括细胞增殖与毒性检测平台、代谢分析系统、样品分离与制备试剂盒、专业染色试剂盒以及生化试剂系列。

▎AkrivisBio产品线
●检测试剂盒(部分产品列表)
①细胞增殖与毒性检测:AkrivisBio公司提供多种细胞毒性及增殖检测方案,包括用于药物筛选的MTT法、MTS法和LDH检测法。我们的试剂盒操作简单、高效便捷,可兼容多种样本类型。
②代谢分析:AkrivisBio公司提供涵盖碳水化合物代谢、脂质代谢、氨基酸合成等多条通路的代谢检测试剂盒,用于精准定量代谢物、分析物及中间产物。试剂盒具有精度高、速度快、操作简便等优势,适用于各类样本,并兼容酶标仪、荧光酶标仪及分光光度计等常用检测设备。
③样品分离与制备试剂盒:产品线包含:细胞器分离富集试剂盒(线粒体、溶酶体等)、细胞组分分离试剂盒(细胞核、胞质蛋白、膜蛋白等)、以及TCA/PCA/SSA去蛋白试剂盒(用于分析前去除样本蛋白质)。这些试剂盒提供便捷高效的样本处理方案,分离后的样本可完美适配Western blot等下游应用。
④染色试剂盒:通过特异性染料或抗体标记目标分子,实现DNA、蛋白质、脂质、细胞器及特定标志物的可视化观测。AkrivisBio公司提供脂质染色试剂盒、细胞活性/毒性双染试剂盒、β-半乳糖苷酶染色试剂盒等系列产品,满足各类研究需求。
| 品名 | 货号 | Size |
| LDH Based Cell Cytotoxicity Assay | CPT-0101 | Includes reagents for 500 wells |
| Crystal Violet Cell Cytotoxicity Assay | CPT-0102 | Includes reagents for 1000 wells |
| MTT Cell Proliferation Assay | CPT-0103 | Includes reagents for 1000 wells |
| MTS Cell Proliferation Assay | CPT-0104 | Includes reagents for 2500 wells |
| Quick Cell Proliferation Assay | CPT-0105 | Includes reagents for 500 and 2500 wells |
| Ready-to-use Cell Proliferation Reagent | CPT-0106 | Includes reagents for 2500 wells |
| Neutral Red Cell Cytotoxicity Assay | CPT-0107 | Includes reagents for 1000 wells |
| Oil Red O Lipid Staining Kit | COS-0101 | To stain two plates (6- 12-, 24- or 96-well) or five 100 mm culture dishes |
| Senescence Staining Assay | COS-0102 | To stain 4X 24-, 12-, 6-well plates |
| Live vs. Dead Cell Differentiation Staining Kit | COS-0103 | Includes reagent for staining 4 x 24-well plates. |
| Beta-galactosidase Staining Kit | COS-0104 | Includes reagents to stain 20 x 12-well plates or the equivalent volume of 6 or 24-well plates. |
| Alkaline Phosphatase Staining Kit | COS-0105 | Includes reagents to stain 96-, 48-, 24-, 12-, 6-well plates |
| Cell-Based Lysosomal Cytotoxicity Dual Staining Kit | COS-0106 | 50 assays |
| CaspACTIV Active Caspase-9 Staining Kit | COS-0107 | 25 wells, 100 wells |
| Annexin V-FITC Apoptosis Detection Kit | COS-0108 | 25 wells, 100 wells |
| Protein Myristoylation Assay | COS-0109 | 100 wells |
●即用型微孔板
| 品名 | 货号 | Size |
| Glucose RediPlate | RP-0122C | 96 wells / 40 samples using background control or 80 samples without background controls |
| Pyruvate Kinase RediPlate | RP-0107C | 96 wells / 40 samples using background control or 80 samples without background controls |
| Alkaline Phosphatase Activity Assay | RP-0109C | 480 wells |
●生化试剂(部分产品列表)
| 品名 | 货号 | CAS号 | 分子式 |
| 2-Hexyl-4-Pentynoic Acid | B2834 | 96017-59-3 | C₁₁H₁₈O₂ |
| YW3-56 (hydrochloride) | B2858 | - | C₂₇H₃₂ClN₅O₂.HCl |
| Destruxin A | B2947 | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| Destruxin A | B2947 (Copy) | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| DTBA | B3242 | 1363376-98-0 | C₄H₁₁NS₂·HCl |
| Telotristat | B338 | 1033805-28-5 | C₂₅H₂₂ClF₃N₆O₃ |
| AZD-4573 | B3319 | 2057509-72-3 | C₂₂H₂₈ClN₅O₂ |
| Eltoprazine hydrochloride | B2301 | 98206-09-8 | C₁₂H₁₆N₂O₂HCl |
| 3-TYP | B2322 | 120241-79-4 | C₇H₆N₄ |
| LY-2510924 | B2360 | 1088715-84-7 | C₆₂H₈₇N₁₃O₁₁ |
| Salermide | 1873 | 1105698-15-4 | C₂₆H₂₂N₂O₂ |
| Atractyloside Potassium Salt | B2441 | 102130-43-8 | C₃₀H₄₄K₂O₁₆S₂ |
| PZ-2891 | B2460 | 2170608-82-7 | C₂₀H₂₃N₅O |
| Lanreotide Acetate | B2464 | 127984-74-1 | C₅₄H₆₉N₁₁O₁₀S₂ · xC₂H₄O₂ |
| Vesatolimod | B2555 | 1228585-88-3 | C₂₂H₃₀N₆O₂ |
| YW3-56 (hydrochloride) | B2858 | - | C₂₇H₃₂ClN₅O₂.HCl |
| Sodium dichloroacetate | B3080 | 2156-56-1 | C₂HCl₂NaO₂ |
| Destruxin A | B2947 | 6686-70-0 | C₂₉H₄₇N₅O₇ |
| Pibrentasvir | B2168 | 1353900-92-1 | C₅₇H₆₅F₅N₁₀O₈ |
| STF-62247 | B2210 | 315702-99-9 | C₁₅H₁₃N₃S |
| Anastrozole | B2177 | 120511-73-1 | C₁₇H₁₉N₅ |

艾美捷科技代理代理MYOCEA品牌产品。
MYOCEA是一家专注于肌肉生物学和细胞培养技术的公司,致力于为科研和工业应用提供创新的肌肉细胞模型和相关产品。MYOCEA 以其独特的MyoCells™技术平台而闻名,该平台能够生成高度功能化的肌肉细胞,广泛应用于药物开发、毒理学测试、食品科学和再生医学等领域。MyoCells™技术平台能够生成与体内肌肉细胞高度相似的体外模型,为研究肌肉生物学和相关疾病提供了强大的工具。MYOCEA主要产品和技术包括:
(1)MyoCells™ 平台
MyoCells™ 肌肉细胞,高度功能化的肌肉细胞,具有与体内肌肉相似的生理特性。
MyoCells™ 培养基,专为肌肉细胞优化,支持细胞生长和功能维持。
MyoCells™ 试剂盒,包含细胞、培养基和实验指南,方便用户快速开展实验。
(2)药物开发工具
肌肉毒性测试,用于评估药物对肌肉细胞的毒性。
肌肉功能分析,提供高灵敏度的收缩性和代谢活性检测工具。
个性化药物筛选,基于患者来源的肌肉细胞模型,支持个性化医疗研究。
(3)食品科学应用
细胞培养肉研究,提供高质量的肌肉细胞,用于细胞培养肉开发。
食品添加剂测试,用于评估食品添加剂对肌肉细胞的影响。
(4)再生医学工具
肌肉再生研究,提供肌肉细胞模型,用于研究肌肉再生和修复机制。
组织工程,支持肌肉组织工程和生物材料开发。
(5)定制服务
定制肌肉细胞模型,根据客户需求开发特定的肌肉细胞模型。
合同研究服务(CRO),提供从实验设计到数据分析的全流程服务。

艾美捷科技代理Anatrace品牌。
Anatrace公司一直是高纯度去污剂的重要生产商,其产品被广泛应用于膜蛋白结构生物学领域,其范围包括从破坏细胞膜的化合物到稳定或溶解不稳定的大分子和蛋白质的产品。除了货架产品组合外,Anatrace的化学家还可以开发量身定制的专业解决方案,提供定制合成服务和专家分析工作。产品包括:
(1)洗涤剂:自第一款去污剂十二烷基麦芽糖苷(DDM) 以来,目前已拥有50多种独特的去污剂。
(2)通用实验室试剂:除了特种表面活性剂和高纯度去污剂外,还提供一系列常见的去污剂,非常适合初始蛋白质提取和许多其他分子生物学应用。
(3)脂质:脂质和类脂质表面活性剂系列将帮助您将稳定过程提升到一个新的高度。
(4)结晶工具:Anatrace一直是膜蛋白工作中使用的去污剂的黄金标准。
(5)特种洗涤剂/产品:用来解决膜蛋白和大分子稳定性和溶解度的许多挑战。
<<< " data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Anatrace品牌"> 艾美捷科技代理Anatrace品牌地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771149750
传真:18771997407
邮箱:sales@amyjet.com
0.1191